Cosmo, Glenmark secure UK MHRA approval of Winlevi for treatment of acne

MT HANNACH
0 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

Scientists load laboratory machines

ER Limited / Digitalvision productions via Getty Images

Cosmo Pharmaceuticals NV (OTCPK: CMOPF) Monday said that Glenmark received approval from the Medicines and Health Products Regulatory Agency (MHRA) to market Winlevi in ​​the United Kingdom.

Winlevi is the first topical acne treatment in almost 40 years with a

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *